-
Symbol
-
NBY on NYSE
-
Investment type
-
Equity / Common Stock, par value $0.01 per share
-
Latest Disclosed Shares Owned
-
6,388,000 shares
-
Security Ownership %
-
5%
David E. Lazar ownership in NovaBay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY)
29 Jan 2026 - David E. Lazar has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,388,000 shares of NovaBay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY).
This represents 5% ownership of the company.
In their previous filing dated 17 Oct 2025, David E. Lazar had reported owning 1,502,080 shares, indicating an increase of +325%.
.